Erchonia Europe to launch Zerona(R) laser at 5CC
Erchonia Europe, the exclusive supplier of Erchonia laser products across 28 European countries, is pleased to announce the Europe-wide launch of the Zerona® laser at this year's 5-Continent-Congress (5CC) for Lasers and Aesthetic Medicine.
- (1888PressRelease) September 02, 2011 - Founded in 1996, Erchonia is a world leading provider of Low Level Laser Technology for medical applications, working to advance the applications of 3LT through independent research and product development with the backing of the scientific and medical communities. Unlike other laser body sculpting technologies, Zerona has been proven through double-blind clinical trials to emulsify adipose tissue without the potentially harmful effects of adipocyte cell death. Zerona's unique mode of action leads to evacuation of fatty materials from unilocular adipocytes by inducing the formation of transitory pores within the cell membrane, emulating the body's natural mechanism of fat depletion while reducing serum LDL and triglyceride levels. Following comprehensive evaluations, Zerona received USA FDA approval and European CE marking in 2010. Over 75,000 patients have since been treated in the US with more than a 90 % satisfaction rate, and the first units have now been installed in Europe.
Visit Erchonia Europe at Booth M 15A to learn more about Erchonia's pioneering approach and the Zerona body sculpting procedure.
About Erchonia Europe
Erchonia Europe, based in Oxford, is a provider of Low Level Laser Technology (3LT) for medical applications, including the potential treatment of nail fungal infections and acne, as well as complex wound management. Erchonia Europe's Zerona® laser is a pain-free 3LT body-sculpting procedure designed to reduce fat and contour the body without invasive surgery. Zerona has been proven through double-blind clinical trials to emulsify adipose tissue and, ffollowing comprehensive evaluations, it received USA FDA approval and European CE marking in 2010. For additional information, visit www.erchoniaeurope.com
For further information, contact:
Jeremy Fry
CEO
Erchonia Europe LLP
The Innovation Centre
99 Milton Park
Abingdon
Oxon
OX14 4RY
Tel: +44 (0)1235 841590
Email: enquiries ( @ ) erchoniaeurope dot com
www.erchoniaeurope.com
###
space
space
Contact Information
- Jeremy Fry
- Erchonia Europe
- Erchonia Europe LLP
The Innovation Centre
99 Milton Park
Abingdon
Oxon
OX14 4RY
- OX14 4RY
- Voice: 44 (0)1235 841590
- Visit our Site
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam